FDA Reverses Refusal-to-File on mRNA Flu Vaccine
After notifying Moderna last week that its application for review of its mRNA-1010 flu vaccine would not be reviewed for possible approval, the FDA reversed
Day: February 18, 2026
After notifying Moderna last week that its application for review of its mRNA-1010 flu vaccine would not be reviewed for possible approval, the FDA reversed